What Does Wegovy 7.2 mg Actually Cost in the UK?

You've found the 7.2 mg dose, now you're wondering what it costs to stay on it

That's the most common situation. People reach the 7.2 mg maintenance dose after several months of titration, realise it's working, and then want to know what the ongoing cost looks like. It's a fair question, and the honest answer is: it depends on the provider and what their price genuinely covers.

UK private Wegovy treatment has become more expensive since Eli Lilly's September 2025 list-price increase for Mounjaro pushed the broader GLP-1 market upward. Semaglutide prices have tracked similarly. Across the UK private market, monthly costs at the higher doses are typically reported somewhere in the range of £150 to £375, depending on dose, provider, and what's bundled in, though these figures are widely reported estimates, not a fixed price list, and vary. The MHRA's approval of the 7.2 mg pen, announced on GOV.UK in April 2026, means this format is now commercially available, but not every provider will have confirmed stock of every format at every moment. Specific availability is worth confirming at consultation.

One thing the headline number won't tell you: whether a consultation fee, prescription charge, or delivery cost sits behind it. Those additions can close much of the gap between what looks cheap at first glance and what you actually pay at checkout.

What headline Wegovy prices often leave out

The first price you see advertised is rarely the full picture. Some providers charge separately for the initial consultation, sometimes £20, sometimes more. Others add a prescription fee on top, or charge for delivery. Aftercare, dose-review calls, and clinical sign-off before each repeat are sometimes listed as extras rather than included as standard.

For a medicine that requires ongoing titration and regular prescriber oversight, those aren't trivial omissions. NICE's recommendation for semaglutide (TA875) was specifically built around the expectation of multidisciplinary support and clinical monitoring, because that's what safe, effective treatment looks like in practice. A price that strips out that layer is a price that asks you to manage your own treatment.

It's also worth knowing that Wegovy 7.2 mg is licensed for adults with a BMI of 30 or above, not for lower BMIs, and not for the cardiovascular indication at that dose. If you're exploring Wegovy as a treatment option, your eligibility needs a proper clinical look, not a tick-box form.

A breakdown of how Wegovy pricing sits across doses (including the lower maintenance steps) is covered on our Wegovy cost overview page. If you started titration recently and want to understand what the 0.5 mg dose costs compared to where you are now, that page sets out the figures clearly.

How nume prices Wegovy 7.2 mg, and why we're not trying to be cheapest

We don't enter the race to the bottom on price. A single, transparent monthly figure covers your consultation, your prescription, your treatment, tracked next-working-day delivery (DPD, plain box, nothing on the outside to hint at what's inside), and seven-day aftercare, no extras, no subscription, no automatic renewal. Every repeat order goes through a fresh clinical review before it's approved.

What that means in practice: you're not paying a base price and then discovering the consultation is billed separately. The number you see is the number you pay. Patients who want to understand how the Wegovy 1 ml pen is priced will find that detail useful when comparing formats across providers. Our current treatment pricing is shown on the treatment page, we don't print per-pen prices in editorial copy, because those figures move and the context around them matters more than the number alone.

The prescribers who review consultations at our GPhC-registered pharmacy (registration 9012878) are reviewing your full clinical picture, not just your BMI. Transfer patients and patients requesting a dose increase both go through evidence checks as part of that process. You can read more about our clinical team here.

For a direct comparison of what different Wegovy doses cost and what's driving price variation, our dedicated Wegovy 7.2 mg price guide covers that in more detail, and if you want a focused look at the full cost breakdown for the 7.2 mg dose specifically, that page goes into the figures in depth.

Why 'cheapest' is the wrong test for a prescription medicine

The MHRA has been clear: fake weight-loss pens are a real and ongoing problem. In 2025 alone, approximately 20 million doses of illegally traded weight-loss medicines (around £45 million street value) were seized, and the first UK site manufacturing counterfeit tirzepatide pens was raided in Northampton. Some fake pens have contained insulin rather than the labelled medicine, with genuinely dangerous consequences for people who had no idea what they were injecting.

The red flags are consistent: sellers offering GLP-1 medicines without a prescription, prices significantly below the market range, social media listings, and discount codes from accounts you can't verify. For any online pharmacy, the right check is the GPhC pharmacy register, a legitimate provider will be listed there. Suspect sellers can be reported directly via the MHRA Yellow Card scheme.

The question worth asking about any Wegovy 7.2 mg price isn't whether it's cheap. It's whether the supply chain is verifiable, whether a real prescriber reviewed your case, and whether someone is available if something goes wrong. Those aren't luxury extras. They're the basic minimum for a prescription medicine that changes how your body handles food. Speak to our prescribers through the free consultation to see whether Wegovy is right for you.